Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201)
Phase 2
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000009539
- Lead Sponsor
- OSAKA-LCSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Symptomatic brain metastasis (2) Have another active malignancy (3) Current or previous history of hemoptysis (4) Evidence of tumor invading large vessel on imaging (5) Evidence of tumor invading trachea or main bronchus on imaging (6) Have received radiation therapy to lesions of lung (7) Currently have or have a history of a cardiac effusion which requires treatment (8) Brain infarction within 1 year (9) Problematic infection (10) Scheduled operation (11) Active radiation pneumonitis or esophagitis (13) Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy (14) Decision of ineligibility by a physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method